Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Medical Oncology (Northwood, London, England)|May 25, 2006
Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancerMónica Fernández-Sánchez, Armando Gamboa-Dominguez, Norma Uribe, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|February 20, 2015
Impact of a federal program on response rate & survival, in a cohort of patients with diffuse large B-cell lymphoma. Analysis in a single national reference institution in MéxicoMyrna Candelaria, Juan Labardini-Mendez, Ana F Ramírez-Ibarguen, et al.
Revista Medica De Chile|January 31, 2024
[Primary testicular NK/T cell lymphoma. Case report and review of literature]Alejandro Avilés-Salas, Andrea Nallely Heredia-Jara, Laura Felisa Peña-Carvajalino, et al.
BMC Cancer|September 3, 2004
HER2 expression in cervical cancer as a potential therapeutic targetAlma Chavez-Blanco, Victor Perez-Sanchez, Aurora Gonzalez-Fierro, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2018
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approachMyrna Candelaria, Derlis Gonzalez, Francisco Javier Fernández Gómez, et al.
Archives of Medical Research|April 26, 2005
Multimodal treatment of locally advanced cervical cancerAlfonso Dueñas-González, Lucely Cetina-Pérez, Luis Fernando Oñate-Ocaña, et al.
Cancer Cell International|October 4, 2006
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancerLucia Taja-Chayeb, Alma Chavez-Blanco, Jorge Martínez-Tlahuel, et al.
World Journal of Surgical Oncology|February 18, 2009
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patientsLucely Cetina, Alicia Garcia-Arias, Myrna Candelaria, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 17, 2012
Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemiaEduardo Cervera, Myrna Candelaria, Omar López-Navarro, et al.
Pageof 8